Monday, November 11, 2013

Greg Helps Start Scripps Consulting Club


Business skills and knowledge are rarely covered in science PhD coursework. A new organization at The Scripps Research Institute (TSRI) aims to provide such training and resources for postdoctoral fellows, graduate students and others considering a career in management consulting, venture capitalism, business development or strategic management. Response to its initial events indicates the Scripps Consulting Club (SCC) has found a ready audience.

“Some 50 people came to the California launch meeting and more than 25 showed up at the Florida meeting,” said SCC President Joseph Lai, a fourth-year graduate student in the Gottesfeld lab. “Clearly, there appears to be a demand for exposure to the business world and career options.” 



[continue reading...]

Monday, April 8, 2013

Greg Receives NSF GRFP Fellowship

Daniel Murin of the Ward and Ollmann-Saphire labs, Ruben Martinez of the Baran lab, and Greg Solis of the Petrascheck/Kelly labs at The Scripps Research Institute (TSRI) have received National Science Foundation (NSF) Graduate Research Fellowships.

The highly competitive fellowships—13,000 submitted applications for 2,000 awards in 2013—recognize and support outstanding graduate students in NSF-supported disciplines who are pursuing research-based master's and doctoral degrees at accredited U.S. institutions. Fellows receive three years of support as well as international research and professional development opportunities.


[continue reading...]

Monday, March 18, 2013

Sunitha Awarded Muscular Dystrophy Association Grant

Sunitha Rangaraju, a postdoctoral research scientist at the Scripps Research Institute in La Jolla, Calif., was awarded an MDA development grant totaling $180,000 over a period of three years to determine whether compounds that slow certain aspects of aging may be therapeutic in amyotrophic lateral sclerosis (ALS).

The biggest known risk factor for ALS is advancing age, suggesting that the processes that contribute to aging also may contribute to ALS. This led Rangaraju and colleagues to hypothesize that compounds that slow the aging process might be valuable as drugs against ALS. To that end, their lab screened more than 89,000 molecules for those that delay aging and extend life span in C. elegans, a small worm that is widely used to study aging.


[continue reading...]